These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33011894)

  • 1. Common Brain Structural Alterations Associated with Cardiovascular Disease Risk Factors and Alzheimer's Dementia: Future Directions and Implications.
    Lamar M; Boots EA; Arfanakis K; Barnes LL; Schneider JA
    Neuropsychol Rev; 2020 Dec; 30(4):546-557. PubMed ID: 33011894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors, tract-based structural connectomics, and cognition in older adults.
    Boots EA; Zhan L; Dion C; Karstens AJ; Peven JC; Ajilore O; Lamar M
    Neuroimage; 2019 Aug; 196():152-160. PubMed ID: 30980900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer's disease.
    Boots EA; Schultz SA; Oh JM; Larson J; Edwards D; Cook D; Koscik RL; Dowling MN; Gallagher CL; Carlsson CM; Rowley HA; Bendlin BB; LaRue A; Asthana S; Hermann BP; Sager MA; Johnson SC; Okonkwo OC
    Brain Imaging Behav; 2015 Sep; 9(3):639-49. PubMed ID: 25319359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Regional Brain Structural Differences With Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance.
    Suzuki H; Venkataraman AV; Bai W; Guitton F; Guo Y; Dehghan A; Matthews PM;
    JAMA Netw Open; 2019 Dec; 2(12):e1917257. PubMed ID: 31825506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study.
    Ramirez J; McNeely AA; Scott CJM; Masellis M; Black SE;
    Alzheimers Dement; 2016 Feb; 12(2):203-210. PubMed ID: 26208292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease.
    Araque Caballero MÁ; Suárez-Calvet M; Duering M; Franzmeier N; Benzinger T; Fagan AM; Bateman RJ; Jack CR; Levin J; Dichgans M; Jucker M; Karch C; Masters CL; Morris JC; Weiner M; Rossor M; Fox NC; Lee JH; Salloway S; Danek A; Goate A; Yakushev I; Hassenstab J; Schofield PR; Haass C; Ewers M
    Brain; 2018 Oct; 141(10):3065-3080. PubMed ID: 30239611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of white matter tract pathology in frontotemporal dementia.
    Mahoney CJ; Ridgway GR; Malone IB; Downey LE; Beck J; Kinnunen KM; Schmitz N; Golden HL; Rohrer JD; Schott JM; Rossor MN; Ourselin S; Mead S; Fox NC; Warren JD
    Hum Brain Mapp; 2014 Aug; 35(8):4163-79. PubMed ID: 24510641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer's disease with cerebrovascular disease.
    Gallart-Palau X; Serra A; Lee BST; Guo X; Sze SK
    J Neuroinflammation; 2017 Sep; 14(1):175. PubMed ID: 28865468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort.
    Salvadó G; Brugulat-Serrat A; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2019 Jan; 11(1):12. PubMed ID: 30678723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    Price CC; Tanner JJ; Schmalfuss IM; Brumback B; Heilman KM; Libon DJ
    J Alzheimers Dis; 2015; 48(3):833-47. PubMed ID: 26402109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.
    Grammas P
    J Neuroinflammation; 2011 Mar; 8():26. PubMed ID: 21439035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.
    Barber R; Scheltens P; Gholkar A; Ballard C; McKeith I; Ince P; Perry R; O'Brien J
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):66-72. PubMed ID: 10369824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
    Blusztajn JK; Aytan N; Rajendiran T; Mellott TJ; Soni T; Burant CF; Serrano GE; Beach TG; Lin H; Stein TD
    J Alzheimers Dis; 2023; 95(4):1623-1634. PubMed ID: 37718815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.